Skip to content

Impact of Endometrial Compaction on Clinical Pregnancy Rate in Frozen Embryo Transfers

Impact of Endometrial Compaction on Clinical Pregnancy Rate in Frozen Embryo Transfers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06583265
Enrollment
80
Registered
2024-09-04
Start date
2024-01-01
Completion date
2024-09-30
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF

Brief summary

To find out if the percentage of endometrial compaction is correlated to clinical pregnancy rate in down regulated frozen embryo transfer cycle. Endometrial compaction is the change in endometrial thickness between the end of the estrogen only phase and the day of embryo transfer. In concept, the compaction of the endometrium after progesterone initiation indicates that the endometrium is responsive to progesterone and could therefore be used as a proxy for endometrial receptivity predictability of FET cycle outcome

Interventions

DRUGObservational

To observe if endometrial compaction ≥ 5% in down regulated FET cycles increases clinical pregnancy rate.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Women undergoing down regulated cycles frozen embryo transfer. * Women at age group 20-35 years old. * Day 5 embryos will be transferred.

Exclusion criteria

* Chromosomal abnormality in either partner (As this could lead to cycle cancellation). * Uterine malformation or any intrauterine condition affecting the pregnancy outcomes of FET, such as endometrial polyps, uterine cavity adhesion, history of endometrial tuberculosis, hydrosalpinx with a reflux into uterine cavity (As the might not be candidates for IVF cycle till correction). * Recurrent implantation failure, defined as 2 or more previous failed trials (Other confounding factors might of present which could affect the results). * Cycles of patients with persistent endometrial thickness \<7mm during treatment protocol (Due to cycled cancelation).

Design outcomes

Primary

MeasureTime frameDescription
clinical pregnancy rate3-4 wks after ETClinical pregnancy rate, determined by visualizing a viable embryo within the uterine cavity by ultrasound 3-4 weeks after ET, in patients with endometrial compaction in down regulated FET cycles in comparison to non endometrial compaction.

Secondary

MeasureTime frame
Percentage of change of endometrial thickness between the end of estrogen administration only phase and the day of embryo transfer.3-4 wks after ET
Chemical pregnancy rates, detected by positive hCG test in the absence of pregnancy findings on TVUS3-4 wks after ET
Number of estrogen administration days10 days before ET

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026